Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > My Theory ! A change is in the air and sp set to move !
View:
Post by Oden6570 on Aug 08, 2021 8:08am

My Theory ! A change is in the air and sp set to move !

After watching Roger buy almost monthly for some time and then seeing all Senior tlt Mgt purchase the last shares Late April early May IMHO indicates a deal is cooking the nature of I know not. No purchases since May 4th 2021 Rodger 


I may be way off but if you scroll further you will see Roger's pattern of buying has ceased as well Hatchey and Mandell first action or buying in some time. 

V.TLT | Insiders | Theralase Technologies Inc. | Stockhouse

My Theory is this buying pattern stopped for a reason , we are about to get are long awaited big new's . Roger does not want to break the Insider rules. I am just suprised our CEO has so little skin in the game.
· What is material inside information?

 

Courts define “material inside information” as information which, if known, could reasonably be expected to affect the value of the Company’s stock, or which would affect the investment judgment of a person making a decision to buy or sell the stock. Information is considered “material” if there is a substantial likelihood that it would be considered important by a reasonable investor in deciding whether to purchase or sell stock, or other securities, or if the information would be viewed by the reasonable investor as having significantly altered the total mix of information available to the investor before making the purchase or sale. The information need not be the determining factor, but must assume actual significance in the investor’s deliberations. Examples of inside information include:

 

  - a material change in anticipated earnings (up or down);
  - proposed public or private offerings of securities;
  - loan defaults;
  - pending or proposed mergers, acquisitions, joint ventures, or sales of significant assets or other strategic plans;
  - regulatory approvals, patent registrations or issuances, investigations, etc.;
  - a proposed offering or issuance of new securities;
  - the occurrence of, or important developments in, major disputes, claims or significant litigation (whether or not meritorious);
  - a change in management;
  - new product announcements; and
  - the gain or loss of significant customers, suppliers or business partners.

 

Material inside information can be either positive or negative.

 

Information is “nonpublic” if it has not been disclosed to the public generally. For information to be considered public, there should be some evidence that it has been widely disseminated and that the investing public has had time to absorb the information. You should generally consider information nonpublic until after the second business day after the information is publicly released, such as by press release or widely circulated public disclosure documents filed with the SEC, such as prospectuses or 10-K, 10-Q or 8-K reports. For example, if information is disclosed via press release on a Monday, it can be considered public beginning that Thursday.

https://www.sec.gov/Archives/edgar/data/1164964/000101968715004168/globalfuture_8k-ex9904.htm

W
ell go at it people am I crazy ? or just maybe the long awaited climb begins and the dream becomes more real !

Comment by Rumpl3StiltSkin on Aug 08, 2021 10:57am
A lot of those items could have been highlighted there Oden. NDD would suggest the line item 5 places down, then there is the item 4 places down :-|
Comment by Oden6570 on Aug 08, 2021 11:16am
I am really trying to stay hopeful here :- ) buying by insiders stopped around new Theralase institute and Gov of Canada taking over vaccine research, not to mention with trials now being done in US exposure to more influential eyes. So I have mixed my dream and Theory together but man oh man this has been the longest hold of stock in my lifetime. I need some love from this investment :-)
Comment by tamarindo1 on Aug 08, 2021 11:48am
Oden6570: I am really trying to stay hopeful here :- ) buying by insiders stopped around new Theralase institute and Gov of Canada taking over vaccine research, not to mention with trials now being done in US exposure to more influential eyes. So I have mixed my dream and Theory together but man oh man this has been the longest hold of stock in my lifetime. I need some love from this investment :- ...more  
Comment by Rumpl3StiltSkin on Aug 08, 2021 8:30pm
I think TLT will get us there Oden.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250